Literature DB >> 6772162

Specific inactivation of lysosomal glycosidases in living fibroblasts by the corresponding glycosylmethyl-p-nitrophenyltriazenes.

O P Van Diggelen, H Galjaard, M L Sinnott, P J Smith.   

Abstract

1. beta-D-Galactopyranosylmethyl-p-nitrophenyltriazene can specificag detectable changes in cell viability or the activities of other hydrolases. 2. beta-D-Glucopyranosylmethyl-p-nitrophenyltriazene behaves similarly towards lysosomal beta-glucosidase, but also inactivates some alpha-glucosidase. 3. Both beta-galactosidase and beta-glucosidase activities in triazene-treated confluent fibroblast cultures recover exponentially; if zero-order enzyme production is assumed, turnover times of 10 and 5 days respectively can be estimated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772162      PMCID: PMC1161875          DOI: 10.1042/bj1880337

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  Sialidosis: a review of human neuraminidase deficiency.

Authors:  J A Lowden; J S O'Brien
Journal:  Am J Hum Genet       Date:  1979-01       Impact factor: 11.025

2.  Identity of beta-glucosidase, beta-xylosidase and one of the beta-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-beta-D-glycosides studies in cases of Gaucher's disease.

Authors:  P A Ockerman
Journal:  Biochim Biophys Acta       Date:  1968-08-06

3.  The turnover of hamster fibroblast lysosomal beta-D-glucuronidase.

Authors:  M J Warburton; C H Wynn
Journal:  Biochem J       Date:  1977-01-15       Impact factor: 3.857

4.  Demonstration of a deficiency of beta-xylosidase activity in various forms of Gaucher's disease.

Authors:  Y B Chiao; S P Peters; W F Diven; R E Lee; R H Glew
Journal:  Metabolism       Date:  1979-01       Impact factor: 8.694

5.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

6.  GM1 ganglioside beta-galactosidase. A. Purification and studies of the enzyme from human liver.

Authors:  A G Norden; L L Tennant; J S O'Brien
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

7.  Prenatal diagnosis of sialidosis with combined neuraminidase and beta-galactosidase deficiency.

Authors:  W J Kleijer; A Hoogeveen; F W Verheijen; M F Niermeijer; H Galjaard; J S O'Brien; T G Warner
Journal:  Clin Genet       Date:  1979-07       Impact factor: 4.438

8.  Isolation of beta-galactosidase and beta-glucosidase from brain.

Authors:  S Gatt; M M Rapport
Journal:  Biochim Biophys Acta       Date:  1966-03-07

9.  Affinity labelling with a deaminatively generated carbonium ion. Kinetics and stoicheiometry of the alkylation of methionine-500 of the lacZ beta-galactosidase of Escherichia coli by beta-D-galactopyranosylmethyl-p-nitrophenyltriazene.

Authors:  M L Sinnott; P J Smith
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

10.  The effect of intralysosomal sucrose storage on the turnover of hamster fibroblast lysosomal and Golgi-apparatus enzymes.

Authors:  M J Warburton; C H Wynn
Journal:  Biochem J       Date:  1976-08-15       Impact factor: 3.857

View more
  10 in total

1.  The effects of sucrose loading on lysosomal hydrolases.

Authors:  T Kato; S Okada; T Yutaka; H Yabuuchi
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

2.  The biochemical diagnosis of lysosomal storage diseases--a review of five years experience.

Authors:  I J Wallace; C A McCusker; D McCormick
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

3.  In vivo inhibition of beta-glucosidase and beta-mannosidase activity in rats by 2-deoxy-2-fluoro-beta-glycosyl fluorides and recovery of activity in vivo and in vitro.

Authors:  J D McCarter; M J Adam; N G Hartman; S G Withers
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

4.  Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.

Authors:  A D'Azzo; A Hoogeveen; A J Reuser; D Robinson; H Galjaard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

5.  Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse.

Authors:  P M Hoogerbrugge; B J Poorthuis; A E Romme; J J van de Kamp; G Wagemaker; D W van Bekkum
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Inhibition of glycoprotein oligosaccharide processing in vitro and in influenza-virus-infected cells by alpha-D-mannopyranosylmethyl-p-nitrophenyltriazene.

Authors:  W McDowell; A Tlusty; R Rott; J N BeMiller; J A Bohn; R W Meyers; R T Schwarz
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

7.  Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency.

Authors:  O P Van Diggelen; A W Schram; M L Sinnott; P J Smith; D Robinson; H Galjaard
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

Review 8.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

Review 9.  Genetically-encoded tools for cAMP probing and modulation in living systems.

Authors:  Valeriy M Paramonov; Veronika Mamaeva; Cecilia Sahlgren; Adolfo Rivero-Müller
Journal:  Front Pharmacol       Date:  2015-09-15       Impact factor: 5.810

Review 10.  Dissecting glycoprotein biosynthesis by the use of specific inhibitors.

Authors:  W McDowell; R T Schwarz
Journal:  Biochimie       Date:  1988-11       Impact factor: 4.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.